Calendar

«« Feb 2008 »»
S M T W T F S
         
1
2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29

Search Box


HealthCentral Top Site Award

IBS Tales Hope Award

LinkBlog

[USA] Think Social Networks, Blogs Can’t Hurt You? Health insurers can use your on-line posts to avoid paying for treatment

Debunking the 'Chemical Imbalance' myth (pdf)

The Johns Hopkins Guide to Antidepressants (Note: requires registration of a valid email address)

Not Depressed, Just British!

  More

Contact

Mailing List

RSS Feeds








Translation

Disclaimer

All content within Anxiety Insights is provided for general information only, and should not be treated as a substitute for the medical advice of your doctor or other health care professional.

Anxiety Insights is not responsible or liable for any diagnosis made by a reader based on the content of this website.

Anxiety Insights is not liable for the contents of any external internet sites listed, nor does it endorse any commercial product or service mentioned or advised on any of the sites.

Always consult your doctor if you are in any way concerned about your health.

recommended links

Depression is Real's Down & Up Show
      Weekly audio-casts from the
      Depression Is Real Coalition

we support

Kiva.org - micro loans that change lives

Moving a Nation to Care : Post Traumatic Stress Disorder and America's Returning Troops, by Ilona Meagher

No Longer Lonely.com

"just don't smoke"


"Don't smoke, whatever you do, just don't smoke."
                        Yul Brynner

Hit Counter

Total: 1,194,079
since: 14 May 2006

Admin console

Log-In

My Blog    My Profile

Leave Message

Add as neighbors






Blogion.com

Blog Flux Directory



Blogarama - The Blogs Directory

blog search directory

BlogTagstic - Blog Directory

Find Blogs in the Blog Directory



LS Blogs

Top Health Sites





Health Blogs - Blog Top Sites

Webloogle Blog Directory

Bloggapedia - Find It!

Abiogen begins phase II anxiety trial

« H E » email
posted Saturday, 8 July 2006

Italian pharmaceutical company Abiogen Pharma has begun a phase II clinical trial evaluating its anti anxiety drug ABIO 08/01.

Being developed to treat clinical anxiety disorders such as Panic Disorder and Generalized Anxiety Disorder, ABIO 08/01 is the first in a new class of non-addictive drugs, different from anxiolytic sedatives.

In phase I studies ABIO 08-01 demonstrated a good profile of safety and tolerability. Moreover, EEG/ERP mapping has provided evidence about peculiar CNS effects of ABIO 08/01. "Comparisons of imaging with previous data arisen from studies conducted at the same investigational centre, present a pharmacological profile of ABIO 08/01 which seems to be extremely innovative," said the company.

tags: panic disorder  drug trial  generalized anxiety disorder  

links: digg this    del.icio.us    technorati    reddit